Variables | N (%) | Trichomonas vaginalis positive N (%) |
---|---|---|
Age (M, SD)* | 42.3 (10.0) | |
Race | ||
African–American | 350 (73) | 70 (20) |
White | 128 (27) | 13 (10) |
Ever smoked | ||
Yes | 193 (40) | 42 (22) |
No | 247 (52) | 34 (14) |
Unknown | 38 (8) | 7 (18) |
Alcohol abuse, ever | ||
Yes | 63 (13) | 15 (24) |
No | 264 (55) | 57 (22) |
Unknown | 151 (32) | 11 (13) |
Illegal drug use, ever | ||
Yes | 125 (26) | 34 (27) |
No | 220 (46) | 38 (17) |
Unknown | 133 (28) | 11 (13) |
Condom use | ||
Yes, consistent | 11 (2) | 6 (55) |
Yes, inconsistent | 18 (4) | 10 (56) |
No | 174 (36) | 16 (9) |
Unknown | 275 (58) | 51 (61) |
HAART therapy at time of visit | ||
Yes | 339 (71) | 47 (14) |
No | 125 (26) | 31 (25) |
Unknown | 14 (3) | 5 (6) |
Absolute CD4 count within 3 months of visit | ||
<200 cells/mm3 | 75 (16) | 14 (19) |
≥200 cells/mm3 | 358 (75) | 56 (16) |
Unknown | 45 (9) | 13 (16) |
HIV viral load within 3 months of visit | ||
>400 copies/ml | 180 (38) | 45 (25) |
≤400 copies/ml | 266 (56) | 31 (12) |
Unknown | 32 (7) | 7 (8) |
Reason for visit | ||
STI screening | 384 (80) | 46 (12) |
Other† | 56 (12) | 23 (41) |
Unknown | 38 (8) | 14 (37) |
*Age was unknown for nine of the women.
†Includes symptomatic (n=52), positive STI test (n=1), contact to STI (n=1) or other (n=2).
HAART, highly active antiretroviral therapy; M, mean; STI, sexually transmitted infection.